Published in Am J Hum Genet on April 01, 1999
Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss. Am J Hum Genet (2000) 2.66
Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. Am J Hum Genet (2004) 1.88
Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76
Genetics and pathological mechanisms of Usher syndrome. J Hum Genet (2010) 1.69
A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet (2001) 1.49
Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II. J Med Genet (2006) 1.27
Identification of two new mutations in the GPR98 and the PDE6B genes segregating in a Tunisian family. Eur J Hum Genet (2008) 1.11
Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations. Orphanet J Rare Dis (2011) 1.09
Whole-exome sequencing identifies novel compound heterozygous mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa. Mol Vis (2013) 1.02
Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II. J Hum Genet (2009) 0.96
Identification of five novel mutations in the long isoform of the USH2A gene in Chinese families with Usher syndrome type II. Mol Vis (2008) 0.95
Targeted next generation sequencing for molecular diagnosis of Usher syndrome. Orphanet J Rare Dis (2014) 0.88
The USH2A c.2299delG mutation: dating its common origin in a Southern European population. Eur J Hum Genet (2010) 0.87
A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variants. Eur J Hum Genet (2015) 0.83
Novel USH2A compound heterozygous mutations cause RP/USH2 in a Chinese family. Mol Vis (2010) 0.82
Identification of candidate regions for a novel Usher syndrome type II locus. Mol Vis (2008) 0.81
Novel deletions involving the USH2A gene in patients with Usher syndrome and retinitis pigmentosa. Mol Vis (2014) 0.79
A mutation in Myo15 leads to Usher-like symptoms in LEW/Ztm-ci2 rats. PLoS One (2011) 0.77
Next-generation sequencing reveals the mutational landscape of clinically diagnosed Usher syndrome: copy number variations, phenocopies, a predominant target for translational read-through, and PEX26 mutated in Heimler syndrome. Mol Genet Genomic Med (2017) 0.75
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature (2001) 7.35
Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature (1997) 6.89
Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol (2000) 6.33
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc Natl Acad Sci U S A (1984) 5.60
Evaluation of the Repliscan system for identification of Enterobacteriaceae. J Clin Microbiol (1978) 5.07
Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med (1999) 4.44
Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome (1997) 4.15
In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species. Antimicrob Agents Chemother (1996) 3.82
A type VII myosin encoded by the mouse deafness gene shaker-1. Nature (1995) 3.71
A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nat Genet (2000) 3.71
Helpers: effects of experimental removal on reproductive success. Science (1982) 3.70
A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet (2000) 3.63
Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet (2000) 3.48
Deprivation payments revisited (again) BMJ (1996) 3.45
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat (2011) 3.40
The mouse Snell's waltzer deafness gene encodes an unconventional myosin required for structural integrity of inner ear hair cells. Nat Genet (1995) 3.40
Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet (1997) 3.26
Reduced climbing and increased slipping adaptation in cochlear hair cells of mice with Myo7a mutations. Nat Neurosci (2002) 3.13
Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clin Genet (1994) 3.04
Cell lineages of the embryo of the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (1978) 2.95
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol (2008) 2.95
Mutations in Cdh23, encoding a new type of cadherin, cause stereocilia disorganization in waltzer, the mouse model for Usher syndrome type 1D. Nat Genet (2001) 2.95
Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet (1997) 2.88
A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet (2000) 2.87
Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J Clin Microbiol (1996) 2.70
Epidermal naevus in Proteus syndrome showing loss of heterozygosity for an inherited PTEN mutation. Br J Dermatol (2006) 2.63
Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression. Mol Cell Biol (2000) 2.56
Sequence interpretation. Functional annotation of mouse genome sequences. Science (2001) 2.54
Myosin VIIa participates in opsin transport through the photoreceptor cilium. J Neurosci (1999) 2.44
Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat Genet (1997) 2.40
Tuberous sclerosis: a genetic study. J Neurol Neurosurg Psychiatry (1969) 2.35
Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother (2002) 2.33
Early recognition of heterozygotes for the gene for dystrophia myotonica. J Neurol Neurosurg Psychiatry (1970) 2.30
Role of myosin VI in the differentiation of cochlear hair cells. Dev Biol (1999) 2.26
A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet (1993) 2.23
Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells. Development (1998) 2.23
A study of retinitis pigmentosa in the City of Birmingham. I Prevalence. J Med Genet (1984) 2.15
In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrob Agents Chemother (2001) 2.14
Organization and evolutionary progress of a dispersed repetitive family of sequences in widely separated rodent genomes. J Mol Biol (1981) 2.10
The frequency of the fragile X chromosome among schoolchildren in Coventry. J Med Genet (1986) 2.06
A radiation hybrid map of mouse genes. Nat Genet (2001) 2.03
Evaluation of a protocol for post-mortem examination of stillbirths. N Engl J Med (1983) 2.01
Primary autosomal recessive microcephaly (MCPH1) maps to chromosome 8p22-pter. Am J Hum Genet (1998) 2.00
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol (2009) 1.99
Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N Engl J Med (1994) 1.98
Cloning of a novel member of the low-density lipoprotein receptor family. Gene (1998) 1.97
A third novel locus for primary autosomal recessive microcephaly maps to chromosome 9q34. Am J Hum Genet (2000) 1.91
Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. Diagn Microbiol Infect Dis (2000) 1.82
Attitudes of deaf adults toward genetic testing for hereditary deafness. Am J Hum Genet (1998) 1.82
Ossifying fibromyxoid tumor of soft parts. A clinicopathological analysis of 59 cases. Am J Surg Pathol (1989) 1.82
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet (1999) 1.82
A community study of severe mental retardation in the West Midlands and the importance of the fragile X chromosome in its aetiology. J Med Genet (1985) 1.80
Susceptibility of multi-resistant Streptococcus pneumoniae to ciprofloxacin, ofloxacin and levofloxacin. J Antimicrob Chemother (1997) 1.79
Natural history of idiopathic torsion dystonia. Adv Neurol (1976) 1.79
Detection of the Pinewood Nematode, Bursaphelenchus xylophilus, Using a Real-Time Polymerase Chain Reaction Assay. Phytopathology (2005) 1.76
Centiles for adult head circumference. Arch Dis Child (1992) 1.71
Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus. Nat Genet (2001) 1.68
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). Antimicrob Agents Chemother (1998) 1.67
Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet (1985) 1.66
The Notch ligand Jagged1 is required for inner ear sensory development. Proc Natl Acad Sci U S A (2001) 1.64
Late complications following permanent pacemaker implantation or elective unit replacement. Heart (1998) 1.63
In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae. Antimicrob Agents Chemother (1998) 1.63
A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment. J Med Genet (2001) 1.61
Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method. Clin Chem (1989) 1.60
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits. J Antimicrob Chemother (1996) 1.59
Microdissection of and microcloning from the short arm of human chromosome 2. Mol Cell Biol (1986) 1.55
The mutational spectrum in Waardenburg syndrome. Hum Mol Genet (1995) 1.55
A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet (2001) 1.49
A clinical and genetic study of chronic proximal spinal muscular atrophy. Brain (1975) 1.48
Usher syndrome in the city of Birmingham--prevalence and clinical classification. Br J Ophthalmol (1997) 1.46
In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers. Antimicrob Agents Chemother (2001) 1.45
Proteus syndrome and immunodeficiency. Arch Dis Child (2000) 1.45
DNA topoisomerase I is essential in Drosophila melanogaster. Proc Natl Acad Sci U S A (1993) 1.44
A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat Genet (1994) 1.44
Survival differences between black and white women with breast cancer. J Surg Oncol (1994) 1.44
Analgesic effect of extracorporeal shock-wave therapy on chronic tennis elbow. J Bone Joint Surg Br (1996) 1.44
Recurrence risks in families of children with symmetrical spasticity. Dev Med Child Neurol (1977) 1.44
A study of retinitis pigmentosa in the City of Birmingham. II Clinical and genetic heterogeneity. J Med Genet (1984) 1.44
In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests. J Antimicrob Chemother (1999) 1.43
Two 46,XX,t(X;Y) females with linear skin defects and congenital microphthalmia: a new syndrome at Xp22.3. J Med Genet (1990) 1.42
A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling. Proc Natl Acad Sci U S A (1994) 1.41
Floating-Harbor syndrome. J Med Genet (1991) 1.40
Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome. Am J Hum Genet (2000) 1.40
Missed prenatal diagnosis of fragile-X syndrome. Prenat Diagn (1989) 1.39
A genetic study of torsion dystonia. J Med Genet (1975) 1.37
Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet (1998) 1.36
Mutation of the Na-K-Cl co-transporter gene Slc12a2 results in deafness in mice. Hum Mol Genet (1999) 1.36